SCHEDULE 13G/A: Douglas M. Singer Discloses 4.44% Passive Stake in Interpace Biosciences, Inc.

Douglas M. Singer has filed an Amendment No. 4 to Schedule 13G, disclosing a beneficial ownership of 4.44% of Interpace Biosciences, Inc.'s common stock.

Summary

• Douglas M. Singer reported beneficial ownership of 195,742 shares of Common Stock, $.01 par value, in Interpace Biosciences, Inc.
• This ownership represents 4.44% of the total class of securities.
• The filing is an Amendment No. 4 to a Schedule 13G, indicating a passive investment purpose.
• Mr. Singer holds sole voting power and sole dispositive power over all 195,742 shares.
• The filing certifies that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently lead to a positive or negative sentiment regarding the company's performance or outlook.

Future Outlook

NA

Industry Context

This filing is a standard disclosure of beneficial ownership by an individual investor, common in the financial industry for transparency regarding significant, non-controlling stakes in publicly traded companies. It does not provide specific insights into Interpace Biosciences' operational or strategic direction, but rather details an individual's investment position.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant individual shareholder's stake, confirming a passive investment approach.

Key Dates

Keywords

Schedule 13G, Beneficial Ownership, Interpace Biosciences Inc., Common Stock, Douglas M. Singer, Passive Investment, SEC Filing